Naniye Malli Cetinbas
3PUBLICATIONS
36CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Mar 03, 2025
XMT-2056, a HER2-Directed STING Agonist Antibody-Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune Cells.Raghida A Bukhalid, Jeremy R Duvall, Kelly Lancaster
|Jul 11, 2024
Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responses.Naniye Malli Cetinbas, Travis Monnell, Jahna Soomer-James
|Sep 29, 2023
Site-Specific Dolasynthen Antibody-Drug Conjugates Exhibit Consistent Pharmacokinetic Profiles across a Wide Range of Drug-to-Antibody Ratios.Susan M Clardy, Alex Uttard, Bingfan Du
Pageof 1
Frequent Collaborators
3 joint publications
Kalli C Catcott
3 joint publications
Timothy B Lowinger
3 joint publications
Marc Damelin
2 joint publications
Dorin Toader
2 joint publications
Caitlin Routhier
2 joint publications
Kelly Lancaster
2 joint publications
Elizabeth Ditty
2 joint publications
Pamela Shaw
2 joint publications
Jeffrey Zurita
2 joint publications
Ling Xu
